Friday, March 31, 2017

Apixaban superior to warfarin for reducing brain bleeds in patients with AFib

Patients with atrial fibrillation showed a substantially reduced risk of dangerous bleeding in the brain, known as intracranial hemorrhage, when taking the newer anticoagulant apixaban compared to those taking warfarin. The study also showed that taking aspirin increased the risk of intracranial hemorrhage, especially in older patients.

More détails